Nemonapride

From Self-sufficiency
Revision as of 11:31, 18 September 2010 by SieBot (Talk) (robot Adding: ja:ネモナプリド)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Nemonapride
File:Nemonapride.png
Systematic (IUPAC) name
N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 75272-39-8
ATC code none
PubChem CID 4452
Chemical data
Formula C21H26ClN3O2
Molar mass 387.90 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Nemonapride (Emilace) is a typical antipsychotic approved in Japan for the treatment of schizophrenia. It was launched by Yamanouchi in 1991. Nemonapride acts as a D2 and D3 receptor antagonist.

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



ja:ネモナプリド